Equity · Healthcare
TWST
NASDAQTwist Bioscience (TWST)
The line runs 125 USD on 10 August through 120.84 USD on 6 November, on a scale from 100 to 250. Days the market did not trade hold the previous close, flat.
- Market cap
- 7.6B USD
- Revenue, year to Sep 2025
- 376.6M USD
- EPS, diluted, year to Sep 2025
- −1.30 USD
- 52-week range
- 25 USD – 204.94 USD
- Avg volume
- 171.8K
- Mentions, 30 days
- 10
- Net sentiment
- +0.07
as of Nov 6, 2026
Have Twist Bioscience (TWST) insiders bought or sold shares recently?
In the 90 days to 8 Nov 2026, Twist Bioscience insiders reported 37 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 May 2026, show no open-market purchase.
Form 4, 90 days to 8 Nov 2026, newest reported trade 3 Nov 2026
Buys 0Sells 37Net sold $116.82MOther filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Cho DennisSee Remarks | Sell | 949 | 128K USD |
| 03 Nov 2026 | Finn Patrick JohnPresident and COO | Sell | 2,565 | 347K USD |
| 03 Nov 2026 | Green PaulaSVP of Human Resources | Sell | 1,007 | 136K USD |
| 03 Nov 2026 | Leproust Emily M.Chief Executive Officer | Sell | 4,573 | 619K USD |
| 03 Nov 2026 | WERNER ROBERT F.Chief Accounting Officer | Sell | 148 | 20K USD |
| 23 Oct 2026 | Finn Patrick JohnPresident and COO | Sell | 2,245 | 302K USD |
| 09 Oct 2026 | Laponis AdamChief Financial Officer | Sell | 2,462 | 385K USD |
| 05 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sell | 4,548 | 919K USD |
| 02 Oct 2026 | Cho DennisSee Remarks | Sell | 9,514 | 1.8M USD |
| 02 Oct 2026 | Finn Patrick JohnPresident and COO | Sell | 25,714 | 4.9M USD |
| 02 Oct 2026 | Green PaulaSVP of Human Resources | Sell | 10,088 | 1.9M USD |
| 02 Oct 2026 | Laponis AdamChief Financial Officer | Sell | 8,057 | 1.5M USD |
| Sold | 37 open-market sales | 774,451 | $116.82M |
Showing the 12 most recent of 37 open-market trades in this window. The figures above count all of them.
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Option exercise | 208,708 | 4.2M USD |
| 18 Aug 2026 | Finn Patrick JohnPresident and COO | Option exercise | 23,355 | 1.6M USD |
| 12 Aug 2026 | Leproust Emily M.Chief Executive Officer | Option exercise | 19,952 | 532K USD |
| 10 Aug 2026 | Leproust Emily M.Chief Executive Officer | Option exercise | 113,318 | 3.0M USD |
Which funds hold Twist Bioscience (TWST)?
11 of the 45 institutional funds we track reported a Twist Bioscience position for the quarter ended 30 Jun 2026 — a combined 790.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| ARK Investment Management | Trimmed | 4,549,803 | 468.1M USD | −28.3% |
| D. E. Shaw & Co. | Added | 1,185,605 | 122.0M USD | +2,441.8% |
| Citadel Advisors | Trimmed | 862,042 | 88.7M USD | −29.4% |
| Marshall Wace | New position | 396,912 | 40.8M USD | |
| Millennium Management | Held (±25%) | 347,148 | 35.7M USD | −1.0% |
| AQR Capital Management | Held (±25%) | 129,391 | 13.3M USD | +3.7% |
| Two Sigma Investments | Added | 94,600 | 9.7M USD | +154.3% |
| Man Group | Trimmed | 58,295 | 6.0M USD | −39.6% |
| Tudor Investment Corp | New position | 31,109 | 3.2M USD | |
| Bridgewater Associates | New position | 18,647 | 1.9M USD |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded Twist Bioscience (TWST)?
The most recent congressional trade disclosed in Twist Bioscience is a sale by Dwight Evans (house, PA), dated 30 Mar 2022.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 30 Mar 2022 | Dwight Evanshouse · Democrat–PA | Sale | 1K USD–15K USD | 26 days |
| 02 Mar 2020 | Dwight Evanshouse · Democrat–PA | Purchase | 1K USD–15K USD | 52 days |
What has been filed or recorded for Twist Bioscience (TWST)?
The filings we hold for Twist Bioscience, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 13,965 shares | 2.1M USD notional · 0.022% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 531 shares | 81K USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 70 shares | 11K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 536 shares | 101K USD notional · 0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 6 shares | 1K USD notional · <0.001% of shares out |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 7 shares | 1K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.56 USD | |
| 30 Jun 2026 | Financials | Total assets | 672.4M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 445.7M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.71 USD | |
| 31 Dec 2025 | Quarterly earnings | Q1 2026 reported | EPS −0.50 USD | |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS −1.30 USD | |
| 30 Sep 2025 | Financials | Revenue | 376.6M USD | fiscal year |
| 30 Sep 2025 | Financials | Net income | −77.7M USD | fiscal year |
| 30 Sep 2025 | Financials | Diluted EPS | −1.30 USD | fiscal year |
| 30 Jun 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.33 USD | |
| 31 Mar 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.66 USD | |
| 31 Dec 2024 | Quarterly earnings | Q1 2025 reported | EPS −0.53 USD | |
| 30 Sep 2024 | Annual report | FY 2024 reported | EPS −3.60 USD |
What is Reddit saying about Twist Bioscience (TWST)?
Reddit mentioned TWST 10 times in the 30 days to 8 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 60% read bullish, 0% bearish and 40% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 10Bullish 60%Bearish 0%Communities 2Against the market +6 points
How do Reddit mentions of Twist Bioscience (TWST) compare with its price?
Share ↗
Where Twist Bioscience (TWST) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 60% | 6 | +0.09 |
| r/stocks | 40% | 4 | +0.05 |
Moves with Twist Bioscience (TWST)
Tickers whose daily Reddit volume rose and fell with Twist Bioscience (TWST)'s. Co-discussion, not price.
PENG +0.83XLU +0.74VST +0.74MES +0.71NVO +0.67STZ +0.66
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Twist Bioscience (TWST): frequently asked questions
What did Twist Bioscience shares close at?
Twist Bioscience closed at 120.84 USD on 6 Nov 2026, up 2.41% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Twist Bioscience’s market cap?
Twist Bioscience is worth 7.6B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Twist Bioscience’s revenue?
Twist Bioscience reported revenue of 376.6M USD for the year ended 30 Sep 2025, as filed with the SEC. See Filings
Have Twist Bioscience insiders bought or sold shares recently?
In the 90 days to 8 Nov 2026, Twist Bioscience insiders reported 37 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 May 2026, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Twist Bioscience?
11 of the 45 funds we track reported a Twist Bioscience position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were ARK Investment Management, D. E. Shaw & Co. and Citadel Advisors. See Funds
Have members of Congress traded Twist Bioscience?
Yes. 2 trades in Twist Bioscience appear in the congressional disclosures we hold; the latest is a sale by Dwight Evans (House, PA) dated 30 Mar 2022, filed 25 Apr 2022. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Twist Bioscience last report earnings?
Twist Bioscience last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of −0.56 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Twist Bioscience?
Twist Bioscience was mentioned 2 times in the last 7 days across the finance subreddits we track, and 10 times over the trailing 30 days. Of the 10 mentions scored for sentiment, 60% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings